Review discusses drug-drug interactions in ICUs, emphasizing prevention strategies and patient safety.
This review article provides an overview of drug–drug interactions (DDIs) in Intensive Care Units (ICUs). It discusses the prevalence, mechanisms, risk factors, commonly involved drug combinations, clinical consequences, and strategies for prevention and management. The article highlights the importance of medication review, clinical pharmacist involvement, and multidisciplinary collaboration to improve patient safety and optimize therapeutic outcomes in critically ill patients. This work is intended for educational and research purposes.
No takes yet. Share an insight, caveat, or question.
Tasin Ahmed (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: